On September 14, 1990 the first gene therapy clinical trial was conducted on a 4-year-old girl named Ashanthi DeSilva to fix a genetic defect. She survived. [1, 2]
It wasn’t until September 2000, following an inquiry into the death of another trial participant, that the US began regulatory oversight for genetic therapy products.